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Background: the biological characteristics of cryopreserved allografts are poorly understood, although many factors are
known to influence their outcome. This study examines the development of transplant vasculopathy in both fresh and
cryopreserved vein allografts and specifically assesses the efficacy of a transport solution containing 10% polyethylene
glycol and 10 lM glutathione (PEG/GSH).
Methods: jugular veins were harvested from control donor rabbits and transplanted as interposition carotid bypass grafts
in 30 New Zealand White (NZW) rabbits. Ten received the fresh jugular veins (fresh). Ten animals received jugular
veins which had been harvested, transported in a physiological solution, cryopreserved and stored in a standard fashion
(cryopreserved). Ten animals received jugular veins which had been harvested, transported in the same solution with the
addition of PEG/GSH, cryopreserved and stored in a standard fashion (PEG/GSH). Cryopreserved jugular veins were
stored for 6 weeks before transplantation. All animals were sacrificed 28 days postoperatively. Vein grafts were perfusion-
fixed and wall dimensions were determined by planimetry.
Results: all transplanted grafts were patent at harvest. The control cryopreserved vein grafts showed a 54% increase in
mean intimal thickness (63–10 lm vs. 41–3 lm; p<0.05) but no change in mean medial thickness (125–9 lm vs.
119–13 lm; p=n.s.) compared to the fresh allograft. Transport of the grafts in PEG/GSH solution resulted in the
abolition of the increase in intimal thickness (41–4 lm; p<0.01) associated with cryopreservation without a change in
medial thickness (140–15 lm; p=n.s.) compared to the cryopreserved allograft.
Conclusion: cryopreserved vein grafts develop significant intimal hyperplasia compared to freshly transplanted grafts.
The use of PEG/GSH in the transport solution significantly reduces this transplant graft intimal hyperplasia to that
which develops in fresh grafts and may lead to improvements in the clinical use of cryopreserved veins.
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Introduction when used as conduits to replace small diameter ves-
sels. There is, therefore, a need for alternative conduits.
Autogenous veins or arteries remain the most common Cryopreserved saphenous vein allografts have been
and most preferred conduits in the revascularisation suggested as a possible off-the-shelf solution for small-
of coronary and peripheral occlusive vascular disease. diameter vessel bypass. Clinical studies of these grafts
With the increasing age of the population and the are limited in both the coronary and peripheral cir-
increasing number of redo operations due to the de- culation, but demonstrate the significant stigma of a
velopment of intimal hyperplasia and accelerated poor patency, irrespective of position.
atherosclerosis in bypass grafts, over one-third of The majority of experimental studies on cryo-
patients will not have one or both of these conduits preservation of vessels and the subsequent biological
available at the time of revascularisation. Prosthetic fate of cryopreserved vessels have used autologous
materials can be used for large diameter vessels; how- tissue. The impressive patency results of these ex-
ever, their patency with present biotechnology is poor perimental studies in animals have not translated to
the clinical allograft arena. There is, thus, a pressing
* Presented at the Young Vascular Surgeons’ Forum – European need to clarify the biology of the cryopreserved al-
Society for Vascular Surgery (12th Annual Meeting; Paris, France,
lograft. A greater knowledge of the changes that occurOctober 1–4, 1998).
in cryopreserved allografts may provide a basis for a† Please address all correspondence to: P.-O. Hagen, Duke University
Medical Center, P.O. Box 3473, Durham, NC 27710, U.S.A. better understanding of the vasculopathy that limits
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Table 1. Dimensional analysis.
Fresh Cryopreserved PEG/GSH p-Value
Lumen (mm2) 12.8–0.5 14.5–0.9 17.1–2.1 n.s.
Intima (mm2) 0.53–0.04 0.84–0.11* 0.60–0.07 0.03
Media (mm2) 1.88–0.23 1.78–0.15 1.86–0.31 n.s.
Intimal ratio 0.23–0.02 0.32–0.04 0.26–0.02 n.s.
Luminal index 11.6–0.93 23.3–1.9† 29.4–1.9†‡ 0.001
The area of the lumen, intima and media from the midpart of the autologous, allogeneic control, cryopreserved and PEG/GSH cryopreserved
vein grafts at 28 days. The intimal ratio (intimal area/[intimal+medial areas]) and the luminal index (luminal diameter/[cross-sectional
wall thickness]) are also presented. Values are the mean–s.e.m. Statistical comparisons are by Kruskal–Wallis ANOVA with Dunn’s post
hoc comparison testing (* p<0.05, † p<0.01 compared to fresh, ‡ p<0.01 compared to cryopreserved grafts).
the patency of cryopreserved vessels. This study uses The hypothesis tested in the present study is that the
development of intimal hyperplasia in a cryopreservedthe rabbit external jugular–carotid-artery bypass
model which offers the benefits of a more extensive allograft will be accelerated compared to a fresh al-
lograft due to the additional cryopreservation insultsdatabase on the biology of venous autografts to which
to compare results obtained from venous allografts. superimposed on the mele´e of other variables as-
sociated with the placement of veins into the arterialPolyethylene glycol (PEG) is a cryopreservation
agent which attenuates tissue immunogenicity,1 and it circulation, and that this injury can be ameliorated
by pretreatment of the vein graft with PEG/GSH inhas been suggested that PEG may reduce the immune
response to allogeneic transplants. Collins et al. ob- solutions employed prior to cryopreservation.
served a 30% reduction in the incidence of rejection
in a group of heart transplant recipients, in which the
donor organ had been stored at 4 °C in a solution
Material and Methodscontaining 5% PEG.2 In a subsequent study, the same
authors showed that PEG produced a modest but Thirty inbred New Zealand White rabbits weighingstatistically significant increase in rat liver allograft 2.0 to 2.5 kg underwent right common carotid arterysurvival time from 9.6 to 11.9 days.3 In these studies bypass grafting: ten received the fresh contralateralthe transplanted organ was merely soaked in the PEG jugular veins from the control rabbits (allogeneic).solution without any attempt at conjugation of PEG Ten animals received jugular veins which had beento any tissue component. harvested, transported in culture media, cryo-The degree of amino acid/protein damage caused preserved and stored for 6 weeks (cryopreservedby a given oxidative stress depends on the nature and group), while ten received jugular veins which hadrelative location of the oxidant or free-radical source, been harvested, transported in culture media withthe proximity of the free radical/oxidant to a protein 10% polyethyleneglycol (PEG) and glutathione (GSH;target, and the nature and concentrations of available 10 lM), cryopreserved and stored for 6 weeks (PEG/antioxidant enzymes and compounds. Cellular redox GSH group). Animals were sacrificed with an overdoseprotection is maintained by a series of intracellular of barbiturates at 28 days after the operation and wereredox-regulating systems which can broadly be di- harvested for morphology and planimetry. Animalvided up into three categories: preventative anti- care complied with the “Principles of Laboratoryoxidants (molecules which sequester transition metals Animal Care” as formulated by the National Societypreventing Fenton reactions; e.g. albumin, caerulo- for Medical Research and the “Guide for the Care andplasmin, haptoglobin, lactoferrin, transferrin), scav- Use of Laboratory Animals” issued by the Nationalenging antioxidants (active scavengers of free radicals; Institutes of Health (U.S. Department of Health andvitamins C, E, A, uric acid and glutathione) and en- Human Services, NIH Publication No. 80-23, revisedzymatic antioxidants.4 In autologous vein grafts short- 1985).term exposure to the free-radical scavenger, des-
ferrioxamine manganese, has been shown to result in
inhibition of intimal hyperplasia after 28 days.5 Our
preliminary data on the use of PEG/GSH during Operative procedures
cryopreservation demonstrated no reduction in cryo-
preservation-induced intimal hyperplasia. We thus Anaesthesia was induced and maintained with sub-
cutaneously injected ketamine hydrochloride (60 mg/kg,elected to treat the vessels prior to cryopreservation.
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Ketaset, Bristol Laboratories, Syracuse, NY, U.S.A.) returned to the laboratory in dry ice and liquid nitro-
gen and stored in liquid nitrogen until surgery. Beforeand xylazine (6 mg/kg, Anased, Lloyd Laboratories,
Shenandoah, IA, U.S.A.). Antibiotic prophylaxis with implantation, the cryopreserved veins were thawed in
the storage container in a water bath at 37 °C for 1030 000 IU/kg of benzanthine and procaine penicillin
(Durapen, Vedco Inc., Overland Park, KA, U.S.A.) was minutes. The vein segment was removed from the
storage medium and placed in serial dilutions of so-given intramuscularly at the time of induction. Surgery
was performed using an operating microscope (JKH lutions containing 0.5 M, 0.25 M and 0 M mannitol and
Dulbecco’s modified Eagle medium with 10% fetal1402, Edward Weck Inc., Research Triangle Park, NC,
U.S.A.) under sterile conditions. After exposure calf serum. Harvest, cryopreservation and thawing
methods were based on previously described protocolsthrough a midline longitudinal neck incision, the left
external jugular vein was identified, its branches were from CryoLifeÔ Cardiovascular (Kennesaw, GA,
U.S.A.).diathermied at a distance from the vein to minimise
injury, and it was dissected out. This vein was kept
moist in a heparinised Ringer’s lactate solution (5 IU/
ml, Heparin, Elkins-Sinn Inc., Cherry Hill, NJ, U.S.A.) Morphologic studies
for approximately 30 minutes while the right common
Following isolation and heparinisation (200 IU/kg,carotid artery of a second recipient rabbit was an-
i.v.), 10 control and experimental vein grafts wereaesthetised, its right common carotid artery was dis-
perfusion fixed in situ at 80 mmHg with an initialsected out and both proximal and distal control
infusion of Hanks Balanced Salt Solution (HBSS, Gibcoobtained. Heparin (200 IU/kg) was administered intra-
Laboratories, Life Technologies Inc., Grand Island, NY,venously. Veins destined for cryopreservation were
U.S.A.) followed by 2% glutaraldehyde made up inprocessed according to the protocol described later.
0.1 M cacodylate buffer (pH 7.2) supplemented withThe cryopreserved vein graft was thawed per a stand-
0.1 M sucrose to give an osmolality of approximatelyard protocol then inserted into the common carotid
300 m Osm. After 60 minutes, the specimen was re-artery in a similar manner to the autologous vein graft
moved, immersed in the glutaraldehyde fixative for aafter 6 weeks. A proximal longitudinal arteriotomy
further 24 hours and then processed for light micro-was made and one end of the reversed jugular vein
scopy. Cross-sections from the mid-part of the graftwas anastomosed to the artery in an end-to-side
were taken for processing. Following standard pro-manner using continuous 10-0 microvascular mono-
cedures, the specimens were stained with a modifiedfilament nylon suture (Ethilon, Ethicon Inc., Som-
Masson’s trichrome and Verhoeff’s elastin stain. Theerville, NJ, U.S.A.). The distal anastomosis was
lumen, the intima and the media were defined andperformed in a similar manner. Throughout the pro-
their dimensions (area and thickness) calculated bycedure, care was taken to avoid unnecessary in-
videomorphometry (Innovision 150, American In-strumentation of the vein graft. The right common
novision Inc., San Diego, CA, U.S.A.).carotid was ligated and divided between the two
For scanning electron microscopy (SEM), mid-por-anastomoses with 4-0 silk sutures. The wound was
tion specimens of glutaraldehyde-fixed grafts wereclosed in layers.
rinsed with the same buffer solution as described
above, dehydrated in ascending concentrations of eth-
anol, transferred to acetone as an intermediate fluid,Cryopreservation
critical point dried in CO2 mounted on specimen stubs
and sputter-coated with gold-palladium according toAll jugular veins destined for cryopreservation were
harvested using a sterile “no touch” technique. The standard techniques. All specimens were examined
in a Philips 500 scanning electron microscope (N.V.veins were flushed with sterile Dulbecco’s modified
Eagle medium with 10% fetal calf serum and pa- Philips, Eindhoven, The Netherlands) at an ac-
celerating voltage of 12 kV. For transmission electronpaverine (3·10-4 M), stored in culture media with or
without 10% PEG and GSH (10 lM) and shipped on microscopy (TEM), representative sections from the
mid-portion of the glutaraldehyde-fixed grafts werewet ice to the tissue preservation laboratory within 24
hours of harvesting. On arrival, the vein segments post-fixed for 1 hour at room temperature in 1%
osmium-tetroxide dissolved in the same cacodylatewere cryopreserved in a solution containing 2.5% chon-
droitin sulphate in 1 M dimethylsulphoxide and 10% buffer as used for the glutaraldehyde solution. After
dehydration in ascending concentrations of ethanol,fetal calf serum in HEPES buffered culture medium;
vein segments were stored at -196 °C in liquid nitro- the specimens were embedded in Epon 812 monomer.
Polymerisation was carried out overnight at 40 °Cgen for 6 weeks in individual containers. Veins were
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Morphology
After 28 days, the intimal surface of the fresh allogeneic
vein grafts were covered by spindle-shaped cells
Fig. 1. (A) Scanning electron micrographs from a fresh allograft showing spindle-shaped cells, termed neointimal cells (asterisks), covering
most of the surface. The periphery of these neointimal cells have ruffled borders (arrowheads). Multiple adherent polymorphonucleocytes,
macrophages (M) and platelets (arrow) can be seen. There are gaps in the luminal surface through which the subendothelial collagen can
be seen in the centre of the micrograph. Original magnification ·1250. (B) Transmission electron micrograph from a fresh allograft after
28 days in the arterial circulation. At the surface, the spindle-shaped neointimal cells noted in scanning electron microscopy are observed
(IC). Arrowheads point to some dense material at the periphery of these cells compatible with contractile fibres. There is mural oedema
(asterisk) and variable collagen between the smooth-muscle cells. L=lumen; SMC=smooth-muscle cells; arrow indicates platelet. Original
magnification ·5600.
followed by 2 days at 60 °C. Ultrathin sections were
cut with a diamond knife on a Reichart ultramicrotome
(Reichart Optische Werke AG, Vienna, Austria),
contrasted with uranyl acetate and lead citrate and
(neointimal cells) which morphologically did not re-examined in a Philips 300 transmission electron micro-
semble endothelial cells (Fig. 1A) in that they displayscope (N.V. Philips) operated at 40 kV.
a well-formed rough endoplasmic reticulum with con-
tractile material located at their peripheries suggestive
of intermediate phenotype smooth-muscle cells (Fig.
Data and statistical analysis 1B). Multiple adherent macrophages and platelets
were seen (Fig. 1A). In addition, there were gaps in
Following determination of dimensions of each vein the surface with exposed subendothelial collagen (Fig.
graft, a ratio of the intimal and medial areas 1A). The underlying smooth-muscle cells had a cyto-
was calculated (intimal ratio=intimal area/ plasm largely filled predominantly with rough endo-
[intimal+medial areas]) and a ratio of the luminal plasmic reticulum (Fig. 1B). Cellular remnants and
diameter to cross-sectional wall thickness (luminal mural oedema were noted in the wall. There were
index=luminal distance/[cross-sectional wall thick- large amounts of collagen interspersed between the
smooth muscles.ness]) was calculated. Morphologic data are expressed
In contrast, the 28-day-old cryopreserved graft hadas the mean–s.e.m. and statistical comparisons are by
an intact endothelium with poorly-demarcated cellKruskal–Wallis ANOVA with Dunn’s post hoc com-
junctions on which were numerous adherent poly-parison testing. A p value less than 0.05 was regarded
morphonucleocytes and macrophages (Fig. 2A). Bothas significant.
the endothelial and underlying smooth-muscle cells
were filled with rough endoplasmic reticulum and
vesicles (Fig. 2B). The presence of such vesicles has
Results been ascribed as a continuing cellular response to
injury. Within the wall of these grafts, cellular remnants
General from dying and disintegrating cells and mural oedema
could be seen.
All animals survived to harvest and all grafts were The PEG/GSH treated cryopreserved graft had an
intact endothelial cell layer with the occasionalpatent at harvest.
Eur J Vasc Endovasc Surg Vol 17, June 1999
Transplant Vasculopathy in Cryopreserved Vein Grafts 497
in overall mean medial thickness (125–9 lm vs.
119–13 lm; p=n.s.) compared to the fresh allograft.
The lumen of the cryopreserved vein grafts was 9%
greater than the fresh allogeneic vein grafts. Transport
Fig. 2. (A) Scanning electron micrographs from a cryopreserved graft showing numerous adherent blood cells. Polymorphonucleocytes
(arrows), macrophages (double arrows) are readily identifiable. One macrophage is shown about to enter a stoma (double arrow with
asterisk). The endothelium appears intact with poorly visualised endothelial cell junctions (arrowheads). Red blood cell, single arrow
with asterisk. Original magnification·1250. (B) Transmission electron micrographs from a cryopreserved graft after 28 days in the arterial
circulation showing endothelial (E) and smooth-muscle cells (SMC), both of which contain rough endoplasmic reticulum. The endoplasmic
reticulum is abutting vesicles, suggesting a synthetic response to injury in these cells. Disintegrating remnants of cells (asterisk) and mural
oedema can also be seen deeper in the wall. On the surface, a macrophage (M) and a polymorphonucleocyte (PMN) are attached. Original
magnification ·4500.
adherent polymorphonucleocyte and macrophage
(Fig. 3A). The underlying intimal and medial smooth-
muscle cells were filled with rough endoplasmic re-
ticulum similar to that seen in the cryopreserved vein
graft (Fig. 3B). Disintegrating smooth-muscle cells and of the cryopreserved vessel in PEG/GSH resulted in
the abolition of this increase in overall mean intimalmural oedema could be seen deeper in the wall, al-
though these were not as extensive as that seen in the thickness (41–4 lm; p<0.01) associated with cryo-
preservation without a change in overall mean medialcryopreserved graft.
thickness (140–15 lm; p=n.s.) compared to the cryo-
preserved allograft (Fig. 4). The luminal areas of the
PEG/GSH vein grafts were 18% greater than those of
Morphometry the cryopreserved vein grafts and 9% greater than
those of the fresh allografts. The luminal index and
At 28 days, the histological responses of the fresh and the intimal ratio of cryopreserved vein grafts was
cryopreserved allogeneic vein grafts were different increased by 50% and 28% respectively compared to
(Fig. 4). At 28 days, the cryopreserved vein graft allogeneic vein grafts due to the significant changes
showed a 54% increase in overall mean intimal thick- in intimal (+37%) and medial (-5%) areas. Com-
paring the cryopreserved vein grafts to the PEG/GSHness (63–10 lm vs. 41–3 lm; p<0.05) but no change
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vein grafts, the luminal index and the intimal ratio
was increased by 21% and decreased by 23% re-
spectively due to the significant changes in intimal
(-29%) and medial (+5%) areas.
Fig. 3. (A) Scanning electron micrographs from a PEG/GSH-treated cryopreserved graft showing intact endothelial cells (E) with stomata
at the cell junctions (arrowheads), some attached polymorphonuclear granulocytes (arrows) and macrophages (double arrows). Original
magnification ·1250. (B) Transmission electron micrographs from a PEG/GSH-treated cryopreserved graft after 28 days in the arterial
circulation showing intact unaltered endothelial cells (E) and underlying smooth-muscle cells (SMC) with rough endoplasmic reticulum
and vesicles suggesting a synthetic phenotype similar to that seen in the cryopreserved graft. A large macrophage (M) is seen deep in
the intimal smooth-muscle-cell layers. Disintegrating smooth-muscle cells and mural oedema are also seen deeper in the wall (not shown)
but is not as extensive as that seen in the cryopreserved graft. Original magnification ·4500.
Discussion
The processes involved in the freezing and thawing
required to prepare, store and reconstitute a cryo-
preserved vein expose the cells in the graft to hy-
pothermia, low temperature without ice formation and
subfreezing temperatures with ice formation. Cryo-
preservation results in unbalanced metabolism, gen-
Fig. 4. A composite photomicrograph showing cross-sections of the eration of free radicals and membrane phase changes
walls of the fresh (A) and cryopreserved (B) and PEG/GSH-treated (liquid to solid) in the cells which can influence the
cryopreserved (C) allogeneic vein grafts at 28 days. H=intimal post-thaw recovery and long-term viability of the cryo-hyperplasia, M=media, and the boundary between the intima and
media is indicated by the arrowheads. Magnification ·250. preserved tissue. Cryoprotective agents and slow rates
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of cooling will ameliorate much of these “cold-in- medial thickness (140–15 lm vs. 71–3 lm; p<0.01)
compared to the autologous vein grafts.13 Physio-duced” injuries. Following cryopreservation and re-
implantation into the donor animal, rabbit autologous logically, the in vitro responses to norepi-
nephrine, histamine and bradykinin were similar in thevein grafts have been shown to have a smooth endo-
thelial cell lining with intact cell junctions by 1, 2 and autologous and allogeneic vein grafts, while serotonin
contractility and endothelial independent relaxation3 months postoperatively.6 In the present study, the
cryopreserved allografts have a significantly improved are enhanced in the allograft compared to the auto-
logous graft. Thus, there are two different vasculo-luminal morphological appearance with far more
endothelial cells and fewer neointimal cells than al- pathies occurring in autografts and allografts, with
intimal hyperplasia being predominant in the auto-lograft controls. Treatment with PEG/GSH prior to
cryopreservation maintained the endothelial mor- graft while an exaggerated medial response is pre-
dominant in the allograft.13 The current study extendsphology similar to that reported for autologous vein
grafts. The presence of an intact endothelium in the these observations to include the first descriptions of
the use of a rabbit vein-graft model to study vein-cryopreserved vein graft has been noted previously
and has been correlated with normal prostacyclin pro- graft intimal hyperplasia in a cryopreserved allograft
setting. Compared to the fresh allograft, the cryo-duction7 and the preservation of endothelial fib-
rinolytic activity.8 In both the fresh and cryopreserved preserved allograft showed a 54% increase in overall
mean intimal thickness, but no change in overall meanallografts there were many adherent platelets, poly-
morphonucleocytes and macrophages on the surface. medial thickness. The lumen of the cryopreserved vein
grafts was 9% greater than the fresh allogeneic veinIn comparison, the addition of PEG/GSH dem-
onstrated a markedly reduced number of adherent grafts. Transport of the cryopreserved vessel in PEG/
GSH resulted in the abolition of the increased intimalleukocytes. In canine fresh allografts and cryo-
preserved allografts, there appear to be no differences thickness associated with cryopreservation without a
change in overall mean medial response. The lumenin platelet deposition immediately after implantation
or at 4 weeks postoperatively.9 of the PEG/GSH cryopreserved vein grafts was 18%
greater than the cryopreserved vein grafts and 9%In the present study, both polymorphonucleocytes
and macrophages could be identified on the surface greater than the fresh allografts. A possible explanation
for the decrease in the intimal response is that glu-of all the grafts, and macrophages were noted within
the intimal smooth-muscle-cell layers. Similarly, an tathione and PEG are both strong antioxidants and
may have prevented oxidant stress in the grafts whichinflammatory infiltrate consisting of granulocytes and
activated lymphocytes was observed in the media and has frequently been shown to be implicated in the
development of intimal hyperplasia. Second, PEG isthe adventitia in 30-day canine allografts.10,11 Treatment
with cyclosporine reduced this inflammatory re- an immunomodulator, and given the observation that
there were markedly decreased numbers of leukocytessponse.10 In contrast to these studies, Deaton has re-
ported a similar histological appearance between on the surface and within the intima of the PEG/
GSH treated grafts, suggesting a reduced exposure toautogenous vein grafts and fresh allografts with the
exception of a heavy infiltrate of leukocytes (T- and cellular mediators, identified in the pathobiology of
intimal hyperplasia. Third, the endothelium appearedB-cells, polymorphonucleocytes) in the fresh allografts
compared to the autogenous vein grafts at 3 months.12 to be in better morphological shape after PEG/GSH
therapy than in its absence, which may well haveThe results from a recent study of rabbit vein al-
lografts13 has shown that the ultrastructural ap- modulated the intimal response to grafting.
The medial response in both grafts was similar andpearance of the intimal cells is not consistent with
normal endothelial cells, and that there are dem- likely reflects a response to the change in haemo-
dynamic stresses induced by placement into the ar-onstrable differences in the intimal or medial reactions
to implantation. In that study, the surface of the allo- terial circulation. This response has been shown to be
exaggerated considerably compared to an autologousgraft was covered by neointimal cells which are mor-
phologically distinct from endothelial cells in that they graft.13 Cryopreserved allografts have been shown to
have extensive medial fibrosis and a significant in-display a well-formed rough endoplasmic reticulum
with contractile material located at their peripheries filtrate consisting of activated macrophages, lym-
phocytes, granulocytes and plasma cells.12,14 Nosuggestive of intermediate phenotype smooth-muscle
cells.13 The rabbit vein allografts show a 51% decrease differences in the intimal or medial reactions after
implantation have been shown in venous autografts,in overall mean intimal thickness (41–3 lm vs.
83–12 lm; p<0.01) and a 97% increase in overall mean fresh allografts and cryopreserved allograft.12 In this
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